Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's Disease
Open Access
- 1 August 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (8), 1536-1544
- https://doi.org/10.1038/mt.2010.107
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Tight Long-term Dynamic Doxycycline Responsive Nigrostriatal GDNF Using a Single rAAV VectorMolecular Therapy, 2009
- Trophic factors therapy in Parkinson's diseasePublished by Elsevier ,2009
- Efficient Transplantation via Antibody-Based Clearance of Hematopoietic Stem Cell NichesScience, 2007
- Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in miceJCI Insight, 2006
- Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's DiseaseNeuron, 2006
- Hypothalamic rAAV-mediated GDNF gene delivery ameliorates age-related obesityNeurobiology of Aging, 2005
- Parkinson's DiseaseNeuron, 2003
- Striatal Transplantation in a Transgenic Mouse Model of Huntington's DiseaseExperimental Neurology, 1998
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991